Antidiabetic Drug Shows Promise in Reducing Stroke Size and Severity
A preclinical study shows a common antidiabetic drug significantly reduces stroke size and brain swelling, offering new possibilities for stroke treatment.
Read MoreA preclinical study shows a common antidiabetic drug significantly reduces stroke size and brain swelling, offering new possibilities for stroke treatment.
Read MoreThe GLP-1 receptor agonist reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction and obesity.
Read MoreThe American Heart Association and the American Red Cross have issued the 2024 first aid guidelines, the first major update since 2010.
Read MoreThe chest-worn device wirelessly transmits ECG data to remote dashboards and uses algorithms to detect and classify cardiac rhythm as bradycardia, tachycardia, normal sinus rhythm, or atrial fibrillation.
Read MoreThe seven-lead patch enables continuous, real-time ECG monitoring for up to 14 days with immediate arrhythmia alerts to clinicians.
Read More